CN102191334A - Signal transducer and activator of transcription (STAT)4 gene polymorphism detection specific primer and liquid-phase chip - Google Patents
Signal transducer and activator of transcription (STAT)4 gene polymorphism detection specific primer and liquid-phase chip Download PDFInfo
- Publication number
- CN102191334A CN102191334A CN2011101538588A CN201110153858A CN102191334A CN 102191334 A CN102191334 A CN 102191334A CN 2011101538588 A CN2011101538588 A CN 2011101538588A CN 201110153858 A CN201110153858 A CN 201110153858A CN 102191334 A CN102191334 A CN 102191334A
- Authority
- CN
- China
- Prior art keywords
- seq
- sequence
- primer
- tag sequence
- phase chip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention discloses a signal transducer and activator of transcription (STAT)4 gene single nucleotide polymorphism (SNP) detection specific primer and a liquid-phase chip. The primer mainly comprises ASPE primers, a microsphere and an amplification primer, wherein each ASPE primer consists of a tag sequence of the 5' terminal and a specific primer for a target gene mutational site of the 3' terminal; the specific primers are over one pair of SEQ ID NO.9 and SEQ ID NO.10 for G97C, SEQ ID NO.11 and SEQ ID NO.12 for G101A, SEQ ID NO.13 and SEQ ID NO.14 for G113A, and SEQ ID NO.15 and SEQ ID NO.16 for G154T; and the microsphere is coated by an anti-tag sequence. The coincidence rate between the detection result of the detection liquid-phase chip provided by the invention and a sequencing method is up to 100 percent; and parallel detection of the mild type and the mutant type of a polymorphism site is realized.
Description
Technical field
The present invention bends in biology field, relates to medical science and biotechnology, concrete a kind of STAT4 gene pleiomorphism detection specificity primer and the liquid-phase chip of relating to.
Background technology
(signal transducer and activator oftranscription, STAT) family is that a class is present in the endochylema, can be activated by the outer polypeptide quasi-molecule of born of the same parents, participates in the protein of gene transcription regulation for signal conduction and transcription activator.Find that up to now this protein families has STAT1a, STAT1b, STAT2, STAT3a, STAT3b, STAT4, STAT5a, STAT5b and STAT6 (totally 9 members), molecular weight is 84～113kDa, and length is between 750～850 amino-acid residues.STAT can bring into play the dual function of signal transduction and transcription activating protein matter, and the interior signal conductive process of the cell of the mediation various kinds of cell factor and somatomedin also activates corresponding target genes, thereby produces biological effect.
Signal transducer and transcription activator 4 (STAT4) are as one of its family member, and that regulates proinflammatory factor and anti-inflammatory factors replys playing an important role in bronchial asthma and anaphylactic disease.STAT4 is positioned at karyomit(e) 2q32.2-32.3, and the encoding sequence of STAT4 is made up of 2247 continuous nucleotides, 748 amino-acid residues of encoding.STAT4 is a key factor on the Th cytodifferentiation path, the immune response of mediation IL-12 and the differentiation of regulating the Th cell.
The STAT4 signal transduction has been brought into play keying action in treatment bronchial asthma process, the pleomorphism site of STAT4 gene has become the inherited genetic factors that influences in the bronchial asthma Hazard Factor.
The STAT4 gene mutation site of target detect of the present invention, it is as shown in the table:
| Sequence number | The content of STAT4 site mutation | Write a Chinese character in simplified form |
| 1 | G → C sudden change takes place in the 97th Nucleotide of SEQ ID NO.33 | G97C |
| 2 | G → A sudden change takes place in the 101st Nucleotide of SEQ ID NO.34 | G101A |
| 3 | G → A sudden change takes place in the 113rd Nucleotide of SEQ ID NO.35 | G113A |
| 4 | G → T sudden change takes place in the 154th Nucleotide of SEQ ID NO.36 | G154T |
At present, the method that the STAT4 gene pleiomorphism is detected, analyzes is a lot, as: direct sequencing, quantitative fluorescent PCR, PCR-RFLP analytical method, TaqMan technology or the like, wherein the most frequently used method have quantitative fluorescent PCR and PCR-RFLP analytical method.Easy and simple to handle, advantages such as the result quick, quantification that quantitative fluorescent PCR has, still, this technology exists sample easily to pollute, and cross reaction easily takes place, the shortcoming that false positive rate is high; And the PCR-RFLP method is based on the change of the restriction enzyme enzyme recognition site that transgenation causes, as losing or produce novel site in the site, by a certain specific fragment of pcr amplification, use the digestion with restriction enzyme amplified production again, the segmental size of electrophoresis observation, this method is used to detect the transgenation that restriction enzyme site changes, and can directly judge genotype, but this method can not be used for not producing the detection in Gene Mutation of new restriction enzyme site.Once more, more than these methods all exist the limitation that detects flux, can only detect a kind of mutation type at every turn, can not satisfy the needs of practical application.
Summary of the invention
One of purpose of the present invention provides the STAT4 gene pleiomorphism and detects liquid-phase chip, and this liquid-phase chip can be used for detecting wild-type and the mutant of STAT4 gene four kinds of common genotype G97C, G101A, G113A and G154T.
A kind of STAT4 gene pleiomorphism detects liquid-phase chip, includes:
(A). the wild-type that designs respectively at every kind of pleomorphism site and the ASPE primer of mutant, every kind of ASPE primer is made up of at the Auele Specific Primer in goal gene mutational site the tag sequence and the 3 ' end of 5 ' end, and described specific primer sequence is selected from: at the SEQ ID NO.9 of G97C and SEQ ID NO.10, at the SEQ ID NO.11 of G101A and SEQ ID NO.12, at the SEQ ID NO.13 of G113A and SEQ ID NO.14, at more than a pair of among the SEQ ID NO.15 of G154T and the SEQ ID NO.16; Described tag sequence is selected from SEQ ID NO.1～SEQ ID NO.8;
(B). microballoon anti-tag sequence bag quilt, that have the different colours coding is arranged, also be provided with the spacerarm sequence in the middle of described anti-tag sequence is connected with microballoon; Described anti-tag sequence is selected from the sequence among SEQ ID NO.17～SEQ ID NO.24, and described anti-tag sequence can be correspondingly with (A) in selected tag sequence complementary pairing;
(C). be used to amplify the primer of needs target sequence that detect, that have corresponding pleomorphism site.
Preferably, described amplimer is: at the SEQ ID NO.25 of G97C and SEQ ID NO.26, at the SEQ ID NO.27 of G101A and SEQ ID NO.28, at the SEQ ID NO.29 of G113A and SEQ ID NO.30, at more than a pair of among the SEQ ID NO.31 of G154T and the SEQ ID NO.32.
Preferably, described ASPE primer is selected from: the sequence that sequence of being made up of SEQ ID NO.1 and SEQ ID NO.9 and the sequence of being made up of SEQ IDNO.2 and SEQ ID NO.10, the sequence of being made up of SEQ ID NO.3 and SEQ ID NO.11 and the sequence of being made up of SEQ IDNO.4 and SEQ ID NO.12, the sequence of being made up of SEQ ID NO.5 and SEQ ID NO.13 reach the sequence be made up of SEQ IDNO.6 and SEQ ID NO.14, be made up of SEQ ID NO.7 and SEQ ID NO.15 reaches more than a pair of in the sequence of being made up of SEQ IDNO.8 and SEQ ID NO.16.
Another object of the present invention provides the Auele Specific Primer that a kind of STAT4 of being used for gene pleiomorphism detects.
Concrete technical scheme is as follows:
A kind of Auele Specific Primer that is used for the detection of STAT4 gene pleiomorphism, it is selected from, at the SEQ ID NO.9 of G97C and SEQID NO.10, at the SEQ ID NO.11 of G101A and SEQ ID NO.12, at the SEQ ID NO.13 of G113A and SEQ IDNO.14, at more than a pair of among the SEQ ID NO.15 of G154T and the SEQ ID NO.16.
Major advantage of the present invention is:
1. the identical rate of the detected result of detection liquid-phase chip provided by the present invention and sequencing is up to 100%.And detect the needed time well below sequencing technologies commonly used, realistic especially application need.Because in very a large amount of Auele Specific Primers, through a large amount of tests, the reaction checking, obtain the liquid-phase chip system of optimum combination, prepared STAT4 gene pleiomorphism detects liquid-phase chip and has extraordinary signal-noise ratio, and there is not cross reaction between designed probe and the anti-tag sequence basically, choosing of tag sequence label, anti-tag sequence label and combining of tag sequence label and concrete ASPE primer, can avoid cross reaction, realize the parallel detection in a plurality of SNP site.
2. pass through design experiences and a large amount of operations of testing of the present inventor's long-term accumulation, from numerous Auele Specific Primers, chosen optimum combination.The genotype of various types is accurately distinguished in the mutational site that the ASPE primer specificity primer of the present invention design can sensitive recognition objective specifically detects; In same reaction system, between the different Auele Specific Primers, do not have cross reaction basically between the pcr amplification product of Auele Specific Primer and non-target detect, detection specificity is good, and cross reacting rate is lower than 3%; Except detecting single site mutation situation, also the polymorphism situation in a plurality of mutational sites of parallel detection simultaneously detects the effect unanimity.
3. detection method step of the present invention is simple, four kinds of pleomorphism sites detect and can finish four amplifications that contain the target sequence in SNP site by a step multiplex PCR, many uncertain factors of existing in the complex operations processes such as repeated multiple times PCR have been avoided, thereby can improve the detection accuracy rate greatly, embodied qualitative, quantitative analysis feature of accurate while.
4. not only to have overcome traditional solid phase chip susceptibility not high in the present invention, and the defective of the repeatability difference of detected result is improved existing liquid-phase chip technology simultaneously, makes prepared microballoon can be applicable to different test items, has very strong expansion.The fluorescent signal value that detects improves greatly, thereby makes the sensitivity that detects be further enhanced, and signal to noise ratio strengthens, and detected result more accurately and reliably.
5. the STAT4 gene mutation detection liquid-phase chip among the present invention provides a kind of technical scheme of different designs for the parallel detection of a plurality of sites several genes type, and has produced significant technique effect.Simultaneously, since technical characterictics such as high-throughput high specific, more realistic demands of applications.The technology trends that on behalf of biological target, liquid-phase chip technology of the present invention will detect.
Embodiment
Embodiment 1STAT4 gene pleiomorphism detects liquid-phase chip, mainly includes:
One, ASPE primer
Wild-type and mutant at STAT4 gene four kinds of common genotype G97C, G101A, G113A and G154T design specific primer sequence respectively.The ASPE primer is made up of " Tag sequence+specific primer sequence ".The ASPE primer sequence is as shown in the table:
The ASPE primer sequence (Tag sequence+specific primer sequence) of table 1STAT4 gene
Every the ASPE primer comprises two parts, and 5 ' end is the specificity tag sequence at anti-tag sequence on the corresponding microballoon, and 3 ' end is mutant or the special primer fragment (shown in above-mentioned table 1) of wild-type.All ASPE primers are synthetic by Shanghai Sangon Biological Engineering Technology And Service Co., Ltd.Every primer after synthetic is mixed with the stock solution of 100pmol/mL respectively with 10mmol/L Tris Buffer.
Two, the microballoon of anti-tag sequence bag quilt
According to designed ASPE Auele Specific Primer fragment, select the tag sequence, reduce between the anti-tag sequence of each microballoon to greatest extent and secondary structure that tag and ASPE Auele Specific Primer fragment may form, corresponding anti-tag sequence is as shown in table 2 on 8 kinds of microballoons numberings of selection and the microballoon:
Corresponding anti-tag sequence on table 2 microballoon numbering and the microballoon
8 kinds of microballoons selecting are available from U.S. Luminex company, with anti-tag sequence bag by with microballoon on.Be connected with the spacerarm sequence of 5-10 T between anti-tag sequence and the microballoon, promptly add the spacerarm sequence of the preceding paragraph 5-10 T before each anti-tag sequence, the anti-tag sequence is synthetic by Shanghai Sangon Biological Engineering Technology And Service Co., Ltd.With synthetic anti-tag sequence sterilization ddH
2O is made into the stock solution of 100nmol/ml.Described spacerarm is to be used for anti-tag and microsphere surface is spaced apart or anti-tag is placed the sequence of hydrophilic environments.By the spacerarm sequence of suitable length is set between anti-tag sequence and microballoon, can reduce sterically hinderedly, improve the efficient of hybridization and the specificity of hybridization.Common spacerarm sequence comprises poly dT, i.e. poly (dT), and oligomerization four polyoxyethylene glycol and (CH2) n spacerarm (n 〉=3) are as (CH2) 12, (CH2) 18 etc.In addition, if exist poly (dA) to disturb, can also use poly (TTG) as spacerarm.Spacerarm of the present invention is preferably 5-10 T, and the process of microballoon bag quilt is as follows:
Get 5 * 10 respectively
6The carboxylated microballoon of individual above-mentioned numbering (available from Luminex company) is suspended in the MES solution of 50ul 0.1mol/L (pH4.5), adds 10ul synthetic anti-tag molecule (100nmol/ml).EDC (N-(3-Dimethylaminopropyl-N-ethylcarbodiimide) (available from the Pierce Chemical company) working fluid of preparation 10ng/ml.Add the EDC working fluid of 2.5ul in the microballoon suspension, constant temperature was hatched 30 minutes, added the EDC working fluid of 2.5ul again, and constant temperature was hatched 30 minutes again.After reaction finished, the Tween-20 washing with 0.02% was once washed once with 0.1% SDS liquid again.The microballoon that is coated with the anti-tag sequence after the washing is resuspended in the Tris-EDTA solution [10mmol/LTris (pH8.0)] of 100ul, and among the 1mmol/LEDTA, 2-8 ℃ keeps in Dark Place.
Three, amplify the primer of the target sequence that contains the mutational site
At STAT4 gene four kinds of common genotype G97C, G101A, G113A and G154T, design of amplification primers amplifies four target sequences that contain pleomorphism site respectively to (seeing Table 3).
Table 3 amplifies the primer of the target sequence with pleomorphism site
All primers are synthetic by Shanghai Sangon Biological Engineering Technology And Service Co., Ltd.Every primer after synthetic is mixed with the stock solution of 100pmol/mL respectively with 10mmol/L Tris Buffer.
Embodiment 2 utilization embodiment 1 described STAT4 gene test liquid-phase chip is to the detection of sample
The prescription of described various solution is as follows:
MES damping fluid (pH5.0) prescription (250ml) of 50mM:
2 * Tm hybridization buffer
| Reagent | The source | Final concentration | The consumption of every 250ml |
| 1MTris-HCl，pH8.0 | SigmaT3038 | 0.2M | 50ml |
| 5MNaCl | Sigma?S5150 | 0.4M | 20ml |
| Triton?X-100 | Sigma?T8787 | 0.16％ | 0.4ml |
Be stored in 4 ℃ after the filtration.
The ExoSAP-IT test kit is available from U.S. USB company.
Biotin labeled dCTP is available from Shanghai Sangon Biological Engineering Technology And Service Co., Ltd.
One, the DNA extraction of sample:
With reference to " molecular cloning " methods involving, obtain DNA to be detected about DNA extraction.
Two, the pcr amplification of testing sample
Design four pairs of primers, one step of multiplex PCR amplifies four target sequences that contain STAT4 gene four kinds of common genotype G97C, G101A, G113A and G154T respectively, the product size is respectively 311bp, 324bp, 389bp and 459bp, and primer sequence (SEQID NO25-32) is seen shown in the above-mentioned table 3.
At first prepare the multiple PCR primer working fluid: the primer stock solution 100ul that respectively gets SEQ ID NO.25-32 respectively mixes and is the multiple PCR primer working fluid in the 1.5ml Eppendorf tube.The multi-PRC reaction system is as follows:
The pcr amplification program is: 95 ℃ of 3min; 94 ℃ of 30s, 56 ℃ of 30s, 72 ℃ of 40s, 30 circulations; 72 ℃ of 10min; 4 ℃ of preservations are standby.
Three, the enzyme of PCR product is cut processing
1. get the reacted product of 7.5ul PCR, add 1ul 10 * SAP damping fluid, 1ul SAP enzyme and 0.5ul Exo-I enzyme;
2.37 ℃ hatch 15min, hatch 15min for 80 ℃, the enzyme that deactivation is unnecessary.The product that enzyme is cut after the processing is directly used in follow-up ASPE primer extension reaction.
Four, site-specific primer extension reaction (ASPE)
Utilize the ASPE primer of above-mentioned design to carry out primer extension reaction, in reaction process, mix biotin labeled dCTP, thereby make a plurality of biotin labeling on the reacted product band.
At first prepare blended ASPE primer working fluid: get gene corresponding wild type to be detected and mutant ASPE primer stock solution 10ul respectively in the 1.5ml Eppendorf tube, add 10mmol/L Tris Buffer and mend, mix and be ASPE mix primer working fluid to 200ul.The system of ASPE reaction is as follows:
Response procedures is: 96 ℃ of 2min; 94 ℃ of 30s, 54 ℃ of 1min, 72 ℃ of 2min, 30 circulations; 4 ℃ of preservations are standby.
Five, hybridization
1. according to the ASPE primer of design, (every kind of microballoon concentration is 2.5 * 10 to the corresponding 8 kinds of optimum microballoons of every group selection
5Individual/ml);
2. the microballoon of getting every kind of numbering of 1ul respectively is in the Eppendorf tube of 1.5ml;
3. microballoon is in 〉=centrifugal the 1-2min of 10000g;
4. supernatant discarded, microballoon is resuspended in 2 * Tm hybridization buffer of 100ul, the vortex mixing;
5. get the above-mentioned microballoon suspension of 25ul in the corresponding hole of 96 hole filter plates, control wells adds the ddH of 25ul
2O;
6. the ASPE reaction solution of getting 5-25ul is used ddH in corresponding hole
2O complements to 50ul;
7. encase 96 orifice plates with lucifuge with masking foil, 95 ℃ of 60s, 37 ℃ of 15min are hatched hybridization;
8. the microballoon after the hybridization is in 〉=centrifugal the 2-5min of 3000g;
9. remove supernatant, microballoon is resuspended in 1 * Tm hybridization buffer of 75ul;
10. microballoon is in 〉=centrifugal the 2-5min of 3000g;
11. microballoon is resuspended in 1 * Tm hybridization buffer of 75ul, adding 15ul concentration is Streptavidin-phycoerythrin (SA-PE) of 10ug/ml;
12.37 ℃ hatch 15min, on the Luminex instrument, detect.
Six, the result detects and data analysis
The reaction after product is by Luminex serial analysis instrument detecting.Detected result is shown in table 4, table 5 and table 6.
Fluorescent value (MFI) and data processing there are following requirement:
1. each site need have an allelotrope MFI at least greater than 300 and greater than 10 * PCR negative control MFI;
2.NET MFI=sample MFI-PCR negative control MFI (NET MFI less than 0 with 0 the expression);
3. satisfy the data of above two conditions, calculate sudden change ratio by following formula:
Sudden change ratio=mutant NET MFI ÷ (mutant NET MFI+ wild-type NET MFI)
4. rule of thumb the sudden change ratio of each detection site is determined threshold value (cut-off value), to divide wild-type homozygote, heterozygote and mutant homozygote.
Use present method to detect 20 increments STAT4 gene polymorphism sites originally, experimental data meets above-mentioned requirements, therefore can calculate their sudden change ratio.Being provided with of threshold value (cut-off value) is as follows: the sudden change ratio range is considered as the wild-type homozygote at 0%-20%; 30%-70% is considered as heterozygote; 80%-100% is considered as the anomaly homozygote.Compare with the liquid-phase chip result with the sequencing detection, calculate the identical rate of classifying method detected result provided by the present invention.Present method detects 20 increments STAT4 genotype detection result and the sequencing result rate of coincideing originally and reaches 100%.As seen STAT4 gene pleiomorphism provided by the present invention detects liquid-phase chip can detect STAT4 gene polymorphism sites type exactly, and the result is reliable and stable.
One of table 4 pattern detection result (MFI)
Table 5 sample STAT4 transgenation ratio (%)
Table 6 sample STAT4 gene mutation type analytical results
| Catalogue number(Cat.No.) | The liquid-phase chip detected result | Sequencing result |
| 1 | Wild-type | Wild-type |
| 2 | 154TT | 154TT |
| 3 | Wild-type | Wild-type |
| 4 | Wild-type | Wild-type |
| 5 | Wild-type | Wild-type |
| 6 | 97CC | 97CC |
| 7 | 154GT | 154GT |
| 8 | Wild-type | Wild-type |
| 9 | Wild-type | Wild-type |
| 10 | 101GA | 101GA |
| 11 | 113AA | 113AA |
| 12 | Wild-type | Wild-type |
| 13 | Wild-type | Wild-type |
| 14 | Wild-type | Wild-type |
| 15 | 97CC | 97CC |
| 16 | Wild-type | Wild-type |
| 17 | Wild-type | Wild-type |
| 18 | Wild-type | Wild-type |
| 19 | Wild-type | Wild-type |
| 20 | Wild-type | Wild-type |
The liquid-phase chip of the ASPE primer that embodiment 3 is different is to the detection of STAT4 gene polymorphism sites
One, the design (selection of Tag sequence and Anti-Tag sequence) of liquid-phase chip preparation
Detecting liquid-phase chip with STAT4 gene G101A and G113A site mutation is example, respectively at the wild-type of G101A and G113A and the specific primer sequence of mutant design ASPE primer 3 ' end, the Tag sequence of ASPE primer 5 ' end then is selected from SEQ ID NO.1-SEQ ID NO.8, accordingly, bag is selected from SEQ ID NO.17-SEQ ID NO.24 by the anti-tag sequence with corresponding tag sequence complementary pairing on microballoon.Specific design is shown in following table (table 7).Synthetic, the anti-tag sequence bag of ASPE primer is described like embodiment 1 and embodiment 2 by microballoon, amplimer, detection method.
The design of table 7 liquid-phase chip preparation
Two, sample detection
Adopt the liquid-phase chip of above-mentioned design preparation, by embodiment 2 described testing processes and method sample 21-40 is detected, detected result is as follows:
Table 8 pattern detection result and Polymorphism Analysis
Table 9 pattern detection result and Polymorphism Analysis
Other is at the liquid-phase chip in different mutational sites, and the ASPE primer uses different Tag sequences, and its result is still reliable and stable, and concrete data are omitted.And the ASPE primer is when selecting among the embodiment 1 collocation of tag sequence and specific primer sequence for use, and effect better (signal to noise ratio is better) is referring to present embodiment test group 2 and test group 5.Other different tag sequences and specific primer sequence collocation, with coming to the same thing of embodiment 2 and present embodiment, concrete data are omitted.
The selection of embodiment 4STAT4 gene pleiomorphism detection specificity primer sequence
One, the design (selection of wild-type and mutant specific primer sequence) of liquid-phase chip preparation
Detecting liquid-phase chip with STAT4 gene G97C and G154T site mutation is example, complementary sequence forward or backwards with this place, mutational site target sequence is a template, respectively at the wild-type of G97C and G154T and the specific primer sequence of mutant design ASPE primer 3 ' end, comprise preferred specific primer sequence and 2 alternative specific primer sequences in the embodiment of the invention 1, as shown in table 10.Wherein,
Interior base is a pleomorphism site.
Table 10 specific primer sequence
Detecting liquid-phase chip with STAT4 gene G97C and G154T site mutation is example, select different specific primer sequences for use at G97C and G154T, the Tag sequence of ASPE primer 5 ' end then is fixed as the best effect sequence among the embodiment 1, and select corresponding with it anti-tag sequence for use, specific design is shown in following table (table 11).Synthetic, the anti-tag sequence bag of ASPE primer is described like embodiment 1 and embodiment 2 by microballoon, amplimer, detection method.
Two of the design of table 11 liquid-phase chip preparation
Two, sample detection
Adopt the liquid-phase chip of above-mentioned design preparation, by embodiment 2 described testing processes and method sample 41-60 is detected, detected result is as follows:
Table 12 pattern detection result and Polymorphism Analysis
Table 13 pattern detection result and Polymorphism Analysis
Can find out that from present embodiment when the ASPE primer was selected among the embodiment 1 collocation of specific primer sequence and tag sequence for use, effect better (signal to noise ratio is better) was referring to present embodiment test group 7 and test group 10.The different specific primer sequences of complementary sequence forward or backwards and the collocation of tag sequence that other derives from place, target detect site sequence still are that specific primer sequence and tag sequence arranging effect are better among the embodiment 1.The specific primer sequence in other different mutational sites and the collocation of tag sequence, with coming to the same thing of embodiment 2 and present embodiment, promptly embodiment 1 selected Auele Specific Primer has better signal to noise ratio, and it is also better to detect effect, and concrete data are omitted.
More than be at the specifying of possible embodiments of the present invention, but this embodiment is not in order to limiting claim of the present invention, does not allly break away from the equivalence that skill spirit of the present invention does and implement or change, all should be contained in the claim of the present invention.
Claims (6)
1. a STAT4 gene pleiomorphism detects liquid-phase chip, it is characterized in that, includes:
(A). the wild-type that designs respectively at every kind of pleomorphism site and the ASPE primer of mutant, every kind of ASPE primer is made up of at the specific primer sequence in goal gene mutational site the tag sequence and the 3 ' end of 5 ' end, and described specific primer sequence is selected from: at the SEQ ID NO.9 of G97C and SEQ ID NO.10, at the SEQ ID NO.11 of G101A and SEQ IDNO.12, at the SEQ ID NO.13 of G113A and SEQ ID NO.14, at more than a pair of among the SEQ ID NO.15 of G154T and the SEQ IDNO.16; Described tag sequence is selected from SEQ ID NO.1～SEQ ID NO.8;
(B). microballoon anti-tag sequence bag quilt, that have the different colours coding is arranged, also be provided with the spacerarm sequence in the middle of described anti-tag sequence is connected with microballoon; Described anti-tag sequence is selected from the sequence among SEQ ID NO.17～SEQ ID NO.24, and described anti-tag sequence can be correspondingly with (A) in selected tag sequence complementary pairing;
(C). be used to amplify the primer of needs target sequence that detect, that have corresponding pleomorphism site.
2. STAT4 gene pleiomorphism according to claim 1 detects liquid-phase chip, it is characterized in that described amplimer is: at the SEQ ID NO.25 of G97C and SEQ ID NO.26, at the SEQ ID NO.27 of G101A and SEQ ID NO.28, at the SEQ ID NO.29 of G113A and SEQ ID NO.30, at more than a pair of among the SEQ ID NO.31 of G154T and the SEQ ID NO.32.
3. STAT4 gene pleiomorphism according to claim 1 detects liquid-phase chip, it is characterized in that described ASPE primer is selected from: the sequence of being made up of SEQ ID NO.1 and SEQ ID NO.9 reaches the sequence of being made up of SEQ ID NO.2 and SEQ ID NO.10, the sequence of being made up of SEQ ID NO.3 and SEQ ID NO.11 reaches the sequence of being made up of SEQ ID NO.4 and SEQ ID NO.12, the sequence of being made up of SEQ ID NO.5 and SEQ ID NO.13 reaches the sequence of being made up of SEQ ID NO.6 and SEQ ID NO.14, more than a pair of in sequence of forming by SEQ ID NO.7 and SEQ ID NO.15 and the sequence formed by SEQ ID NO.8 and SEQ ID NO.16.
4. STAT4 gene pleiomorphism according to claim 1 detects liquid-phase chip, it is characterized in that,
(A) described ASPE primer is: the sequence of being made up of SEQ ID NO.1 and SEQ ID NO.9 reaches the sequence of being made up of SEQ ID NO.2 and SEQ ID NO.10, the sequence of being made up of SEQ ID NO.3 and SEQ ID NO.11 reaches the sequence of being made up of SEQ ID NO.4 and SEQ ID NO.12, the sequence of being made up of SEQ ID NO.5 and SEQ ID NO.13 reaches the sequence of being made up of SEQ ID NO.6 and SEQ ID NO.14, reach the sequence of forming by SEQ ID NO.8 and SEQ ID NO.16 with the sequence of forming by SEQ ID NO.7 and SEQ ID NO.15;
(B). microballoon anti-tag sequence bag quilt, that have the different colours coding is arranged, also be provided with the spacerarm sequence in the middle of described anti-tag sequence is connected with microballoon; Described anti-tag sequence is selected from the sequence among SEQ ID NO.17～SEQ ID NO.24, and described anti-tag sequence can be correspondingly with (A) in selected tag sequence complementary pairing;
(C). described amplimer is: at the SEQ ID NO.25 of G97C and SEQ ID NO.26, at the SEQID NO.27 of G101A and SEQ ID NO.28, at the SEQ ID NO.29 of G113A and SEQ ID NO.30 with at SEQID NO.31 and the SEQ ID NO.32 of G154T.
5. detect liquid-phase chip according to each described STAT4 gene pleiomorphism of claim 1-4, it is characterized in that described spacerarm sequence is 5-10 T.
6. one kind is used for the Auele Specific Primer that the STAT4 gene pleiomorphism detects, it is characterized in that described Auele Specific Primer is selected from: at the SEQ ID NO.9 of G97C and SEQ ID NO.10, at the SEQ ID NO.11 of G101A and SEQ ID NO.12, at the SEQ ID NO.13 of G113A and SEQ ID NO.14, at more than a pair of among the SEQ ID NO.15 of G154T and the SEQ ID NO.16.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110153858.8A CN102191334B (en) | 2011-06-09 | 2011-06-09 | (STAT)4 gene polymorphism detection specific primer and liquid-phase chip |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110153858.8A CN102191334B (en) | 2011-06-09 | 2011-06-09 | (STAT)4 gene polymorphism detection specific primer and liquid-phase chip |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102191334A true CN102191334A (en) | 2011-09-21 |
| CN102191334B CN102191334B (en) | 2014-01-01 |
Family
ID=44600199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110153858.8A Expired - Fee Related CN102191334B (en) | 2011-06-09 | 2011-06-09 | (STAT)4 gene polymorphism detection specific primer and liquid-phase chip |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102191334B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106086231A (en) * | 2016-08-30 | 2016-11-09 | 长沙三济生物科技有限公司 | The Pyrosequencing primer of qualitative detection STAT4 gene type to and test kit |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101250593A (en) * | 2008-02-03 | 2008-08-27 | 广州益善生物技术有限公司 | Papillomavirus detection and parting method as well as liquid phase chip thereof |
-
2011
- 2011-06-09 CN CN201110153858.8A patent/CN102191334B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101250593A (en) * | 2008-02-03 | 2008-08-27 | 广州益善生物技术有限公司 | Papillomavirus detection and parting method as well as liquid phase chip thereof |
Non-Patent Citations (4)
| Title |
|---|
| BYUNG LAE PARK等: "Association analysis of signal transducer and activator of transcription 4 (STAT4) polymorphisms with asthma", 《J HUM GENET》, vol. 50, 3 March 2005 (2005-03-03), pages 133 - 138, XP019374286, DOI: doi:10.1007/s10038-005-0232-1 * |
| HONG YIN等: "Association of STAT4 and BLK, but not BANK1 or IRF5,with primary antiphospholipid syndrome", 《ARTHRITIS & RHEUMATISM》, vol. 60, no. 8, 31 August 2009 (2009-08-31) * |
| 张文静等: "山东汉族人群STAT4基因启动子区域单核苷酸多态与支气管哮喘的相关性", 《山东大学学报（医学版）》, vol. 45, no. 12, 31 December 2007 (2007-12-31), pages 1197 - 1200 * |
| 李美容等: "信号转导子和转录激活子4与支气管哮喘", 《生命的化学》, vol. 30, no. 3, 31 December 2010 (2010-12-31), pages 413 - 416 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106086231A (en) * | 2016-08-30 | 2016-11-09 | 长沙三济生物科技有限公司 | The Pyrosequencing primer of qualitative detection STAT4 gene type to and test kit |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102191334B (en) | 2014-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103374609B (en) | ABO gene mutation detection specific primers and liquid chip | |
| CN102134605A (en) | Single-nucleotide polymorphism (SNP) detection specific primer of CYP2C19 gene and liquid phase chip | |
| CN102191337B (en) | Specific primers and liquid phase chip for detecting polymorphism of cyckin-dependent kinase 5 regulatorysubunit-associated protein 1-like 1(CDKAL1) gene | |
| CN102912002B (en) | ABCB2 gene polymorphism detection specific primers and liquid chip | |
| CN102191334B (en) | (STAT)4 gene polymorphism detection specific primer and liquid-phase chip | |
| CN102181573B (en) | Specific primers and liquid-phase chip for detection of KITLG gene | |
| CN103374607B (en) | ABCC (ATP (adenosine triphosphate)-binding cassette, sub-family C)1 gene mutation detection specific primers and liquid chip | |
| CN102912005B (en) | CYP2C8 gene polymorphism detection specific primers and liquid chip | |
| CN103865986B (en) | CDKN1A detection in Gene Mutation Auele Specific Primer and liquid-phase chip | |
| CN103451272A (en) | BAT3 gene mutation detection specific primer and liquid phase chip | |
| CN102191336B (en) | MYC gene single nucleotide polymorphism (SNP) detection specific primer and liquid-phase chip | |
| CN102952866B (en) | Specific primer and liquid chip for detecting polymorphism of DPYD (dihydropyrimidine dehydrogenase) gene | |
| CN102888444B (en) | Factor II and Factor V genetic polymorphism detection specific primer and liquid-phase chip | |
| CN102191335B (en) | Specific primer and liquid-phase chip for SNP (single nucleotide polymorphism) detection of PIGU (phosphatidylinositol glycan anchor biosynthesis, class U) genes | |
| CN103849675B (en) | RTEL1 detection in Gene Mutation Auele Specific Primer and liquid-phase chip | |
| CN102952872B (en) | Specific primer and liquid chip for detecting polymorphism of SLCO1B3 gene | |
| CN102952868B (en) | Specific primer and liquid chip for detecting polymorphism of SLC15A2 gene | |
| CN102304564B (en) | Specific primers and liquid phase chip for single nucleotide polymorphism (SNP) detection in 15 q 25 section of chromosome | |
| CN102952867B (en) | Specific primer and liquid chip for detecting polymorphism of SLC22A6 gene | |
| CN102226219B (en) | Specific primer and liquid-phase chip for polymorphism detection in chromosome 6q23 section | |
| CN103451273B (en) | TGM5 gene mutation detection specific primer and liquid phase chip | |
| CN103374608B (en) | MTRR (5-methyltetrahydrofolate-homocysteine methyltransferase reductase) gene mutation detection specific primers and liquid chip | |
| CN102952869B (en) | Specific primer and liquid chip for detecting polymorphism of SLCO1B1 gene | |
| CN102952873B (en) | Specific primer and liquid chip for detecting polymorphism of NAT1 (N-acetyltransferase 1) gene | |
| CN102952874B (en) | Specific primer and liquid chip for detecting polymorphism of SLC22A1 gene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent of invention or patent application | ||
| CB02 | Change of applicant information |
Address after: Five 510663 Guangdong city of Guangzhou province Guangzhou Science City Moon Road No. 80, Guangzhou technology innovation base B, C Applicant after: Surexam Biological Technology Co., Ltd. Address before: Five 510663 Guangdong city of Guangzhou province Guangzhou Science City Moon Road No. 80, Guangzhou technology innovation base B, C Applicant before: Guangzhou Yishan Biotechnology Co., Ltd. |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: GUANGZHOU YISHAN BIOTECHNOLOGY CO., LTD. TO: SUREXAM BIOTECHNOLOGY CO., LTD. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140101 Termination date: 20140609 |